News Focus
News Focus
icon url

Protector

12/14/15 5:01 PM

#245593 RE: DewDiligence #245590

DD, not so bad a geuss.

After all they are in the B-I network and they offer a brand new facility.

Then again, one would think that in the production of Biologics the B-I model becomes some less flexible given the need for FDA approval for each line and the need of a root molecule.

So shifting manufacturing around as in the 'bakery' approach where all know and are equipped to make bread, will be more difficult with biologics.

Maybe AVID I will do the bakery-grade productions and all biologics are made in Avid II as of now.